SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001600132-17-000066
Filing Date
2017-06-30
Accepted
2017-06-30 18:43:42
Documents
1
Period of Report
2017-06-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_149886260788685.html 4  
1 FORM 4 wf-form4_149886260788685.xml 4 3051
  Complete submission text file 0001600132-17-000066.txt   4552
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Issuer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEW MOUNTAIN CAPITAL, LLC 787 SEVENTH AVENUE, 49TH FLOOR NEW YORK NY 10019
Business Address
Moura Andre V. (Reporting) CIK: 0001631831 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36845 | Film No.: 17943635